Related Experiment Video
Updated: May 21, 2025

03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
948
Personalized Surveillance Intervals for Intraductal Papillary Mucinous Neoplasm (IPMN): Multicenter Study Using
Claudio Ricci1,2, Stefano Crippa3, Johnathan Hee4,5
1Department of Internal Medicine and Surgery (DIMEC); Alma Mater Studiorum, University of Bologna.
Annals of Surgery
|March 21, 2025
Summary
A new calculator aids personalized surveillance for branch duct intraductal papillary mucinous neoplasms (BD-IPMNs). Patient age and cyst size predict IPMN evolution, guiding tailored follow-up intervals for better management.
Area of Science:
- Gastroenterology and Hepatology
- Oncology
- Medical Informatics
Background:
- Surveillance intervals for low-risk branch duct intraductal papillary mucinous neoplasms (BD-IPMNs) lack established guidelines.
- Accurate risk stratification is crucial for effective patient management and resource allocation.
Purpose of the Study:
- To develop a predictive calculator for personalized surveillance of BD-IPMNs.
- To identify key factors influencing the evolution of BD-IPMNs.
Main Methods:
- An international cohort of BD-IPMNs without worrisome features or high-risk stigmata was analyzed.
- A parametric survival model was developed and validated using derivation and validation cohorts.
- The PANORAMA model was specifically developed and tested for its predictive accuracy.
Main Results:
- Patient age and cyst size were identified as significant predictors of IPMN evolution.
- The conservative PANORAMA model demonstrated superior classification accuracy in the validation cohort.
- The lognormal distribution best fitted the data, with a pooled c-index of 0.689.
Conclusions:
- IPMN evolution is significantly influenced by patient age and cyst size.
- Current semestral/annual follow-up after six months may be overly frequent for low-risk BD-IPMNs.
- The PANORAMA calculator offers a personalized approach to BD-IPMN surveillance.

